PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene & Tropical Medicine, London, United Kingdom.\', \'Barcelona Supercomputing Center (BSC), Barcelona, Spain.\', \'Catalan Institution for Research and Advanced Studies (ICREA), Barcelona, Spain.\', \'Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, United States of America.\', \'Institut für HIV Forschung, Universität Duisburg-Essen, Duisburg, Germany.\', \'Harvard Humanitarian Initiative, Cambridge, Massachusetts, United States of America.\', \'Computational and Systems Biology Program, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America.\', \'Broad Institute of MIT and Harvard, Cambridge, Massachusetts, United States of America.\', \'Space Exploration Technologies Corp, Hawthorne, California, United States of America.\', \'Brigham and Women\'s Hospital, Boston, Massachusetts, United States of America.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1371/journal.pbio.3001531
?:hasPublicationType
?:journal
  • PLoS biology
is ?:pmid of
?:pmid
?:pmid
  • 35143473
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 4.941
?:rankingScore_hIndex
  • 214
?:title
  • SARS-CoV-2 antibodies protect against reinfection for at least 6 months in a multicentre seroepidemiological workplace cohort.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/35143473>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/35143473>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all